jRCT2031260231招募中不适用
A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS
未提供0 个研究点目标入组 3,230 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 3,230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 0age 2month old over 至 0age 6month old under（—）
- 性别
- All
入选标准
- •infants who are 2 months of age in Group
- •infants who are 2 to 6 months of age in Groups 2 and
- •Healthy infants determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study.
排除标准
- •History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis).
- •Major known congenital malformation or serious chronic disorder.
- •Other acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the participant inappropriate for entry into this study.
- •Previous vaccination with any licensed or investigational pneumococcal vaccine, or planned receipt through study participation.
研究者
相似试验
尚未招募
不适用
A double-blind randomized controlled trial to evaluate the efficacy of combined femoral nerve block and selective tibial nerve block for postoperative pain management in high tibial osteotomy.osteoarthritisjRCT103025065060
招募中
不适用
A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes (Enith2)OBESITY OR OVERWEIGHT AND TYPE 2 DIABETESjRCT20612500901,600
进行中（未招募）
不适用
Phase III study of KD2-396Prevention of pertussis, diphtheria, tetanus, poliomyelitis(polio), Hib infection, and hepatitis BjRCT2031250804540
招募中
不适用
A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal CancerMetastatic Colorectal Neoplasms,Microsatellite Stable / Proficient Mismatch Repair Colorectal CancerjRCT203126004768
招募中
不适用
A Phase I/II exploratory clinical trial to evaluate the efficacy and safety of RBBM-S1 in patients requiring lumbar interbody fusion for degenerative lumbar disease, in comparison with the standard treatment of autologous bone grafting.lumbar stenosis, spondylolisthesis, spondylolysis, scoliosis, instability, disc diseasejRCT203125056936